1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Breakdown of aneurysm occlusion rate and complication incidence according to the size of the aneurysm fundus
Fundus Diameter 1–3 mm (n = 59) 4–6 mm (n = 42) 7–9 mm (n = 15) >10 mm (n = 14) Early follow-up 55/59 (93%) 42/42 (100%) 15/15 (100%) 12/14 (85.7%) Complete occlusion 31 (56.4%) 28 (66.7%) 9 (60%) 4 (33.3%) Neck remnant 13 (23.6%) 4 (9.5%) 2 (13%) 7 (58.3%) Sac remnant 7 (12.7%) 5 (11.9%) 3 (20%) 1 (8.3%) Unchanged 4 (7.3%) 4 (9.5%) 1 (6.7%) 0 Midterm follow-up 46/59 (78%) 34/42 (81%) 11/15 (73.3%) 8/14 (57.1%) Complete occlusion 37 (80.4%) 26 (76.5%) 9 (81.8%) 4 (50%) Neck remnant 3 (6.5) 5 (14.7%) 2 (18.2%) 3 (37.5%) Sac remnant 4 (8.7%) 2 (5.9%) 0 1 (12.5%) Unchanged 2 (4.3%) 1 (2.9%) 0 0 Complications 1 Pontine ischemia 1 Pontine ischemia 1 TIA 1 Death 1 CN VI palsy 1 TIA 1 Asymptomatic thrombosis 1 Pulmonary artery occlusion 1 Asymptomatic thrombosis
Note:—CN indicates cranial nerve.